Close

Biohaven Pharma (BHVN) Announces Preliminary 4Q2020 Net Product Revenue For NURTEC ODT

Go back to Biohaven Pharma (BHVN) Announces Preliminary 4Q2020 Net Product Revenue For NURTEC ODT
(NYSE: BHVN) Delayed: 39.61 --0 (-0%)
Previous Close $39.61    52 Week High
Open $39.61    52 Week Low
Day High $39.61    P/E N/A 
Day Low $39.61    EPS
Volume 2,050